Skip to main content
Erschienen in: Neurocritical Care 1/2022

07.09.2021 | Original work

Midline Shift Greater than 3 mm Independently Predicts Outcome After Ischemic Stroke

verfasst von: Morgan E. McKeown, Ayush Prasad, Jessica Kobsa, Ilayda Top, Samuel B. Snider, Chelsea Kidwell, Bruce C. V. Campbell, Stephen M. Davis, Geoffrey A. Donnan, Michael Lev, Kevin N. Sheth, Nils Petersen, W. Taylor Kimberly, Matthew B. Bevers

Erschienen in: Neurocritical Care | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Cerebral edema is associated with worse outcome after acute stroke; however, the minimum clinically relevant threshold remains unknown. This study aimed to identify the minimal degree of midline shift (MLS) that predicts outcome in a cohort encompassing a broad range of patients with acute stroke.

Methods

Patient-level data from six acute stroke clinical trials were combined with endovascular thrombectomy registries from two academic referral centers, generating a combined cohort of 1977 patients. MLS was extracted from the original trial data or measured on computed tomography or magnetic resonance imaging that was obtained a median of 47.0 h (interquartile range 27.0–75.1 h) after stroke onset. Logistic regression was performed to identify predictors of poor outcome and the minimal clinically relevant MLS threshold.

Results

The presence of MLS was a predictor of poor outcome, independent of baseline clinical and demographic factors (adjusted odds ratio 4.46, 95% confidence interval 3.56–5.59, p < 0.001). Examining the full range of MLS values identified, a value of greater than 3 mm was the critical threshold that significantly predicted poor outcome (adjusted odds ratio 3.20 [1.31–7.82], p = 0.011).

Conclusions

These results show that the presence of MLS predicts poor outcome and, specifically, MLS value greater than 3 mm is an important threshold across a variety of clinical settings. These findings may have relevance for the design and interpretation of future trials for antiedema therapies.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kimberly WT, Dutra BG, Boers AMM, et al. Association of reperfusion with brain edema in patients with acute ischemic stroke: a secondary analysis of the MR CLEAN trial. JAMA Neurol. 2018;75(4):1–9.CrossRef Kimberly WT, Dutra BG, Boers AMM, et al. Association of reperfusion with brain edema in patients with acute ischemic stroke: a secondary analysis of the MR CLEAN trial. JAMA Neurol. 2018;75(4):1–9.CrossRef
2.
Zurück zum Zitat Battey TWK, Karki M, Singhal AB, et al. Brain edema predicts outcome after nonlacunar ischemic stroke. Stroke. 2014;45(12):3643–8.CrossRef Battey TWK, Karki M, Singhal AB, et al. Brain edema predicts outcome after nonlacunar ischemic stroke. Stroke. 2014;45(12):3643–8.CrossRef
3.
Zurück zum Zitat Vorasayan P, Bevers MB, Beslow LA, et al. Intravenous glibenclamide reduces lesional water uptake in large hemispheric infarction. Stroke. 2019;50(11):3021–7.CrossRef Vorasayan P, Bevers MB, Beslow LA, et al. Intravenous glibenclamide reduces lesional water uptake in large hemispheric infarction. Stroke. 2019;50(11):3021–7.CrossRef
4.
Zurück zum Zitat Minnerup J, Broocks G, Kalkoffen J, et al. Computed tomography–based quantification of lesion water uptake identifies patients within 4.5 hours of stroke onset: a multicenter observational study. Ann Neurol. 2016;80(6):924–34.CrossRef Minnerup J, Broocks G, Kalkoffen J, et al. Computed tomography–based quantification of lesion water uptake identifies patients within 4.5 hours of stroke onset: a multicenter observational study. Ann Neurol. 2016;80(6):924–34.CrossRef
5.
Zurück zum Zitat Dhar R, Yuan K, Kulik T, et al. CSF Volumetric analysis for quantification of cerebral edema after hemispheric infarction. Neurocrit Care. 2016;24(3):420–7.CrossRef Dhar R, Yuan K, Kulik T, et al. CSF Volumetric analysis for quantification of cerebral edema after hemispheric infarction. Neurocrit Care. 2016;24(3):420–7.CrossRef
6.
Zurück zum Zitat Harston GWJ, Carone D, Sheerin F, Jenkinson M, Kennedy J. Quantifying infarct growth and secondary injury volumes: comparing multimodal image registration measures. Stroke. 2018;49(7):1647–55.CrossRef Harston GWJ, Carone D, Sheerin F, Jenkinson M, Kennedy J. Quantifying infarct growth and secondary injury volumes: comparing multimodal image registration measures. Stroke. 2018;49(7):1647–55.CrossRef
7.
Zurück zum Zitat Ropper AH. Lateral displacement of the brain and level of consciousness in patients with an acute hemispheral mass. N Engl J Med. 1986;314(15):953–8.CrossRef Ropper AH. Lateral displacement of the brain and level of consciousness in patients with an acute hemispheral mass. N Engl J Med. 1986;314(15):953–8.CrossRef
8.
Zurück zum Zitat Davis SM, Donnan GA, Parsons MW, et al. Effects of alteplase beyond 3 h after stroke in the echoplanar imaging thrombolytic evaluation trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol. 2008;7(4):299–309.CrossRef Davis SM, Donnan GA, Parsons MW, et al. Effects of alteplase beyond 3 h after stroke in the echoplanar imaging thrombolytic evaluation trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol. 2008;7(4):299–309.CrossRef
9.
Zurück zum Zitat The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581–7. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581–7.
10.
Zurück zum Zitat Kidwell CS, Jahan R, Gornbein J, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013;368(10):914–23.CrossRef Kidwell CS, Jahan R, Gornbein J, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013;368(10):914–23.CrossRef
11.
Zurück zum Zitat Sheth KN, Elm JJ, Molyneaux BJ, et al. Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol. 2016;15(11):1160–9.CrossRef Sheth KN, Elm JJ, Molyneaux BJ, et al. Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol. 2016;15(11):1160–9.CrossRef
12.
Zurück zum Zitat Kimberly WT, Bevers MB, Demchuk AM, et al. Effect of IV glyburide on adjudicated edema endpoints in the GAMES-RP Trial. Neurology. 2018;91:e2163–9.CrossRef Kimberly WT, Bevers MB, Demchuk AM, et al. Effect of IV glyburide on adjudicated edema endpoints in the GAMES-RP Trial. Neurology. 2018;91:e2163–9.CrossRef
13.
Zurück zum Zitat Torbey MT, Bösel J, Rhoney DH, et al. Evidence-based guidelines for the management of large hemispheric infarction: a statement for health care professionals from the Neurocritical Care Society and the German Society for Neuro-Intensive Care and Emergency Medicine. Neurocrit Care. 2015;22(1):146–64.CrossRef Torbey MT, Bösel J, Rhoney DH, et al. Evidence-based guidelines for the management of large hemispheric infarction: a statement for health care professionals from the Neurocritical Care Society and the German Society for Neuro-Intensive Care and Emergency Medicine. Neurocrit Care. 2015;22(1):146–64.CrossRef
14.
Zurück zum Zitat Ong CJ, Gluckstein J, Laurido-Soto O, Yan Y, Dhar R, Lee JM. Enhanced detection of edema in malignant anterior circulation stroke (EDEMA) score. Stroke. 2017;48(7):1969–72.CrossRef Ong CJ, Gluckstein J, Laurido-Soto O, Yan Y, Dhar R, Lee JM. Enhanced detection of edema in malignant anterior circulation stroke (EDEMA) score. Stroke. 2017;48(7):1969–72.CrossRef
15.
Zurück zum Zitat Fung C, Murek M, Z’Graggen WJ, et al. Decompressive hemicraniectomy in patients with supratentorial intracerebral hemorrhage. Stroke. 2012;43(12):3207–11.CrossRef Fung C, Murek M, Z’Graggen WJ, et al. Decompressive hemicraniectomy in patients with supratentorial intracerebral hemorrhage. Stroke. 2012;43(12):3207–11.CrossRef
16.
Zurück zum Zitat Thomalla G, Hartmann F, Juettler E, et al. Prediction of malignant middle cerebral artery infarction by magnetic resonance imaging within 6 hours of symptom onset: a prospective multicenter observational study. Ann Neurol. 2010;68(4):435–45.CrossRef Thomalla G, Hartmann F, Juettler E, et al. Prediction of malignant middle cerebral artery infarction by magnetic resonance imaging within 6 hours of symptom onset: a prospective multicenter observational study. Ann Neurol. 2010;68(4):435–45.CrossRef
17.
Zurück zum Zitat Irvine HJ, Ostwaldt A-C, Bevers MB, et al. Reperfusion after ischemic stroke is associated with reduced brain edema. J Cereb Blood Flow Metab. 2018;38(10):1807–17.CrossRef Irvine HJ, Ostwaldt A-C, Bevers MB, et al. Reperfusion after ischemic stroke is associated with reduced brain edema. J Cereb Blood Flow Metab. 2018;38(10):1807–17.CrossRef
18.
Zurück zum Zitat Bevers MB, Battey TWK, Ostwaldt A-C, et al. Apparent diffusion coefficient signal intensity ratio predicts the effect of revascularization on ischemic cerebral edema. Cerebrovasc Dis. 2018;45(3–4):93–100.CrossRef Bevers MB, Battey TWK, Ostwaldt A-C, et al. Apparent diffusion coefficient signal intensity ratio predicts the effect of revascularization on ischemic cerebral edema. Cerebrovasc Dis. 2018;45(3–4):93–100.CrossRef
19.
Zurück zum Zitat Carney N, Totten AM, O’Reilly C, et al. Guidelines for the management of severe traumatic brain injury. Neurosurgery. 2017;80(1):6–15.CrossRef Carney N, Totten AM, O’Reilly C, et al. Guidelines for the management of severe traumatic brain injury. Neurosurgery. 2017;80(1):6–15.CrossRef
20.
Zurück zum Zitat Scheulin KM, Jurgielewicz BJ, Spellicy SE, et al. Exploring the predictive value of lesion topology on motor function outcomes in a porcine ischemic stroke model. Sci Rep. 2021;11(1):3814.CrossRef Scheulin KM, Jurgielewicz BJ, Spellicy SE, et al. Exploring the predictive value of lesion topology on motor function outcomes in a porcine ischemic stroke model. Sci Rep. 2021;11(1):3814.CrossRef
Metadaten
Titel
Midline Shift Greater than 3 mm Independently Predicts Outcome After Ischemic Stroke
verfasst von
Morgan E. McKeown
Ayush Prasad
Jessica Kobsa
Ilayda Top
Samuel B. Snider
Chelsea Kidwell
Bruce C. V. Campbell
Stephen M. Davis
Geoffrey A. Donnan
Michael Lev
Kevin N. Sheth
Nils Petersen
W. Taylor Kimberly
Matthew B. Bevers
Publikationsdatum
07.09.2021
Verlag
Springer US
Erschienen in
Neurocritical Care / Ausgabe 1/2022
Print ISSN: 1541-6933
Elektronische ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-021-01341-x

Weitere Artikel der Ausgabe 1/2022

Neurocritical Care 1/2022 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.